World's Best Scientists 2026 revealed!
Sandra J. Horning

Sandra J. Horning

D-Index & Metrics

Medicine

D-Index
89
Citations
44056
World Ranking
12445
National Ranking
6373

Overview

Sandra J. Horning is affiliated with Genentech in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with focused subfields in Hematology and Immunology. The main topics of their work include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, and the study of Immune Cell Function and Interaction.

Their recent scholarly contribution includes a publication titled "Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902," published in 2020 in the journal Transfusion. This work explores novel conditioning regimens in hematologic malignancies.

Frequent collaborators in Sandra J. Horning's research include:

  • Francine M. Foss
  • Victoria Wang
  • Selina M. Luger
  • Opeyemi A. Jegede
  • Kenneth B. Miller

The body of work has been published in at least one known venue:

  • Transfusion

The integration of hematopoietic stem cell transplantation and leukemia research within their portfolio signifies a focus on therapeutic advancement in hematologic disorders, emphasizing clinical applications in immune cell function and disease intervention. Their research intersects clinical immunology and hematology, which aligns with their publication and co-authorship patterns.

Best Publications

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

    Gregory A. Curt;William Breitbart;David Cella;Jerome E. Groopman

  • Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

    Thomas M. Habermann;Edie A. Weller;Vicki A. Morrison;Randy D. Gascoyne

  • The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

    Sandra J. Horning;Saul A. Rosenberg

  • Natural history of and therapy for the indolent non-Hodgkin's lymphomas.

    Horning Sj

  • Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.

    L W Kwak;J Halpern;R A Olshen;S J Horning

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • ABVD Alone versus Radiation-Based Therapy in Limited-Stage Hodgkin's Lymphoma

    Ralph M. Meyer;Mary K. Gospodarowicz;Joseph M. Connors;Robert G. Pearcey

  • High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

    Sandra J. Horning;Nelson J. Chao;Robert S. Negrin;Richard T. Hoppe

  • Female Reproductive Potential after Treatment for Hodgkin's Disease

    Sandra J. Horning;Richard T. Hoppe;Henry S. Kaplan;Saul A. Rosenberg

  • Chemotherapy With or Without Radiotherapy in Limited-Stage Diffuse Aggressive Non-Hodgkin's Lymphoma: Eastern Cooperative Oncology Group Study 1484

    Sandra J. Horning;Edie Weller;Kyung Mann Kim;John D. Earle

  • Randomized Comparison of ABVD Chemotherapy With a Strategy That Includes Radiation Therapy in Patients With Limited-Stage Hodgkin’s Lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group

    Ralph M. Meyer;Mary K. Gospodarowicz;Joseph M. Connors;Robert G. Pearcey

  • Stanford V and Radiotherapy for Locally Extensive and Advanced Hodgkin’s Disease: Mature Results of a Prospective Clinical Trial

    Sandra J. Horning;Richard T. Hoppe;Sheila Breslin;Nancy L. Bartlett

  • Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium

    Daphne de Jong;Andreas Rosenwald;Mukesh Chhanabhai;Philippe Gaulard

  • Granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy

    Nelson J. Chao;Jeffrey R. Schriber;Kevin Grimes;Gwynn D. Long

  • Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG1496 Study

    Howard Hochster;Edie Weller;Randy D. Gascoyne;Thomas M. Habermann

  • Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

    Jane N. Winter;Edie A. Weller;Sandra J. Horning;Maryla Krajewska

  • Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)

    Daphne de Jong;Wanling Xie;Andreas Rosenwald;Mukesh Chhanabhai

Frequent Co-Authors

Richard T. Hoppe
Richard T. Hoppe Stanford University
Ranjana H. Advani
Ranjana H. Advani Stanford University
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Saul A. Rosenberg
Saul A. Rosenberg Stanford University
Leo I. Gordon
Leo I. Gordon Northwestern University
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Roger A. Warnke
Roger A. Warnke Stanford University
Robert S. Negrin
Robert S. Negrin Stanford University
Karl G. Blume
Karl G. Blume Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to medicine offers flexible career advancement and specialized knowledge. Many working nurses look to advance their skills and credentials through rn to fnp bridge programs, which provide a pathway from an Associate Degree in Nursing (ADN) to becoming a Family Nurse Practitioner (FNP). These online bridge programs allow for continued employment while elevating clinical expertise.

For those interested in health and wellness, online nutrition degrees are ideal for building careers in dietetics, food science, or wellness coaching. These programs merge medical science with nutrition, opening doors to roles in public health and private practice.

Another in-demand option is pursuing a Master of Health Administration online. The best online mha programs help future healthcare leaders develop crucial management skills needed in hospitals, clinics, and other settings.

Additionally, registered nurses seeking upward mobility without onsite requirements can consider the best online rn to bsn programs without clinical requirements. These programs offer academic progression and professional growth, all in a flexible online format.

Best Scientists Citing Sandra J. Horning

Trending Scientists

Recently Published Articles